Professor Baopeng Tang
Urumqi (China)
Membership:
FESC Member
Follow
Contributor content
Journal
Cryoballoon ablation vs. antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: <em>the multicentre randomized CEPAF trial</em>
1 September 2026
